Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGuild Esports . Share News (GILD)

Share Price Information for Guild Esports . (GILD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.225
Bid: 0.20
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.05 (25.00%)
Open: 0.225
High: 0.225
Low: 0.225
Prev. Close: 0.225
GILD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Guild Esports Eyes Boosting US Investor Base

Mon, 22nd Feb 2021 13:53

Guild Esports PLC - London-based owner and developer of e-sports teams - Files application with New York, US-based OTC Markets Group Inc for shares to be cross-traded publicly on the OTCQB Venture Market, to become more widely available to US investors. Notes trading on US OTC market would have no impact on existing shares trading on the Main Market of the London Stock Exchange and no new shares will be issued as part of the cross-trade. Says the cross-trading facility will be provided through OTC Markets Group if the application is successful.

"We would like to make Guild available to US markets in order to gain access to a broader investor base and enhance our visibility in North America, where many of our potential sponsors and fans are based. Dual trading on the OTC markets represents an important development for the company," says Executive Chair Carleton Curtis.

Current stock price: 6.78 pence, up 6.8% on Monday

Year-to-date change: up 21%

By Zoe Wickens; zoewickens@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Oct 2020 20:26

IN BRIEF: Guild Esports Signs Team To Compete In Valorant Game

IN BRIEF: Guild Esports Signs Team To Compete In Valorant Game

Read more
19 Oct 2020 11:54

Guild Esports Inks GBP3.6 Million Sponsorship Deal With Fintech Firm

Guild Esports Inks GBP3.6 Million Sponsorship Deal With Fintech Firm

Read more
21 Mar 2018 07:00

FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division

* GSK reallocating budget to key new drugs, top 10 markets * Pharma head says commercial revamp matches R&D changes * Cancer a big pipeline focus, promise lies from Ben March 21

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.